Tech Company Financing Transactions
Sunbird Bio Funding Round
Edbi, Eli Lilly and Company and ClavystBio invested in a $14 million venture round for Sunbird Bio. The round closed on 10/16/2024.
Transaction Overview
Company Name
Announced On
10/16/2024
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand the clinical development of its proprietary blood-based diagnostic platform that has demonstrated potential to support earlier, more accurate diagnosis and treatment of Alzheimer's disease, Parkinson's disease and other neurological disorders.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
35 Cambridgepark Drive 100
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. While other technologies can detect proteins that pass through the blood-brain barrier, they cannot differentiate between healthy proteins and disease-specific proteins that aggregate.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John McDonough
Chief Financial Officer
Jonathan Ang
Chief Technical Officer
Peter Maimonis
Co-Founder
Nicholas Ho
Founder
Huilin Shao
VP - Bus. Development
Mario Morken
VP - Operations
Nicole Tsang
VP - Product Management
Carine Lim
Browse more venture capital transactions:
Prev: 10/16/2024: Ikerian venture capital transaction
Next: 10/16/2024: Lumachain venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs